John J. Kirby insider trades

Open-market stock purchases and sales by John J. Kirby, Interim CFO at Verrica Pharmaceuticals Inc, from SEC Form 4 filings since Aug 20, 2012.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -3%.

Recent trades

DateStockTradeValue
Aug 18, 2026VRCA Verrica Pharmaceuticals IncBought$24.6K
Dec 23, 2025VRCA Verrica Pharmaceuticals IncBought (not open market)—
Nov 25, 2025VRCA Verrica Pharmaceuticals IncBought$15K
Nov 25, 2025VRCA Verrica Pharmaceuticals IncBought$5.6K

Companies traded

  • VRCA Verrica Pharmaceuticals Inc: 3 buys, last Aug 18, 2026
  • ACGN Aceragen, Inc: other filings, last Jan 20, 2023
  • IDRA Idera Pharmaceuticals, Inc: 1 buy, 5 sales, last Jan 6, 2023
  • VPHM Viropharma Inc: other filings, last Jan 24, 2014

Get free alerts when John J. Kirby files a new trade →